Huang Q, Huang F, Chen C, Xiao P, Liu J, Gao Y
Eur Radiol. 2025; .
PMID: 39853332
DOI: 10.1007/s00330-025-11368-9.
Li J, Xu Y, Sun T, Zhang X, Liang H, Lin W
Front Immunol. 2024; 15:1430356.
PMID: 39717782
PMC: 11663840.
DOI: 10.3389/fimmu.2024.1430356.
Gan W, Zhu F, Zeng X, Xiao W, Fang X, Su L
Front Med (Lausanne). 2024; 11:1451677.
PMID: 39588186
PMC: 11586214.
DOI: 10.3389/fmed.2024.1451677.
Sigareva L, Kokorina A, Mikhailova E, Kromsky S, Slizhov P, Aleksandrov V
Bull Exp Biol Med. 2024; 178(1):58-64.
PMID: 39572492
DOI: 10.1007/s10517-024-06282-x.
Faucon A, Lando S, Chrysostomou C, Wijkstrom J, Lundberg S, Bellocco R
J Intern Med. 2024; 297(1):22-35.
PMID: 39537335
PMC: 11636430.
DOI: 10.1111/joim.20024.
To biopsy or not to biopsy a teenager with idiopathic nephrotic syndrome? Biopsy first.
Bigatti C, Chiarenza D, Angeletti A
Pediatr Nephrol. 2024; 40(2):571-578.
PMID: 39251432
PMC: 11666677.
DOI: 10.1007/s00467-024-06510-6.
The clinical and pathological evaluation of patients with immunoglobulin A nephropathy by diffusion tensor imaging and intravoxel incoherent motion diffusion-weighted imaging.
Zhou H, Si Y, Yang L, Wang Y, Xiao Y, Tang Y
Br J Radiol. 2024; 97(1161):1577-1587.
PMID: 39073891
PMC: 11332673.
DOI: 10.1093/bjr/tqae132.
Serum growth differentiation factor 15 as a biomarker for malnutrition in patients with acute exacerbation of chronic obstructive pulmonary disease.
Shi G, Yue L, Tang Z, Wang Y, Hu X, Tong Y
Front Nutr. 2024; 11:1404063.
PMID: 39050134
PMC: 11267996.
DOI: 10.3389/fnut.2024.1404063.
Design of a User-Centered Electronic Health Tool for Glomerular Disease Management.
Oliverio A, Peagler A, Mitchell R, Martinez A, Denham M, Mariani L
Glomerular Dis. 2024; 4(1):105-118.
PMID: 39015841
PMC: 11250522.
DOI: 10.1159/000539169.
Mesangial cell-derived CircRNAs in chronic glomerulonephritis: RNA sequencing and bioinformatics analysis.
Fan J, Li X
Ren Fail. 2024; 46(2):2371059.
PMID: 38946402
PMC: 467094.
DOI: 10.1080/0886022X.2024.2371059.
Clinical Application of Polygenic Risk Score in IgA Nephropathy.
Xu L, Gan T, Chen P, Liu Y, Qu S, Shi S
Phenomics. 2024; 4(2):146-157.
PMID: 38884057
PMC: 11169313.
DOI: 10.1007/s43657-023-00138-6.
Causal association of plasma circulating metabolites with nephritis: a Mendelian randomization study.
Shao F, Yao Y, Weng D, Wang R, Liu R, Zhang Y
Front Nutr. 2024; 11:1364841.
PMID: 38765814
PMC: 11099270.
DOI: 10.3389/fnut.2024.1364841.
C3 Hypocomplementemia Predicts the Progression of CKD towards End-Stage Kidney Disease in IgA Nephropathy, Irrespective of Histological Evidence of Thrombotic Microangiopathy.
Rossi G, Ricco F, Pisani I, Delsante M, Maggiore U, Fiaccadori E
J Clin Med. 2024; 13(9).
PMID: 38731122
PMC: 11084933.
DOI: 10.3390/jcm13092594.
Terpenes in the management of chronic kidney disease.
Kulkarni P, Yeram P, Vora A
Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(9):6351-6368.
PMID: 38683370
DOI: 10.1007/s00210-024-03098-4.
Fulminant Eye Infection in a Patient With Nephrotic Syndrome: A Case Report.
Kulkarni A, Thool A, Daigavane S
Cureus. 2024; 16(3):e55842.
PMID: 38590483
PMC: 11000746.
DOI: 10.7759/cureus.55842.
Complement and Podocytopathies: Do We Have a New Biomarker?.
Blasco M, Bomback A
Kidney Int Rep. 2024; 9(3):520-522.
PMID: 38481505
PMC: 10927946.
DOI: 10.1016/j.ekir.2024.01.037.
The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapies.
Cheung C, Barratt J, Liew A, Zhang H, Tesar V, Lafayette R
Front Nephrol. 2024; 3:1346769.
PMID: 38362118
PMC: 10867227.
DOI: 10.3389/fneph.2023.1346769.
Defining the threshold: triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio's non-linear impact on tubular atrophy in primary membranous nephropathy.
Guan M, Wu L, Cheng Y, Qi D, Chen J, Song H
Front Endocrinol (Lausanne). 2024; 15:1322646.
PMID: 38327562
PMC: 10847559.
DOI: 10.3389/fendo.2024.1322646.
Incidence and outcomes of kidney replacement therapy for end-stage kidney disease due to primary glomerular disease in Europe: findings from the ERA Registry.
Abd ElHafeez S, Kramer A, Arici M, Arnol M, Asberg A, Bell S
Nephrol Dial Transplant. 2024; 39(9):1449-1460.
PMID: 38327216
PMC: 11483622.
DOI: 10.1093/ndt/gfae034.
Application of nanotechnology in the treatment of glomerulonephritis: current status and future perspectives.
Zhan H, Zhang X, Chen X, Cheng L, Wang X
J Nanobiotechnology. 2024; 22(1):9.
PMID: 38169389
PMC: 10763010.
DOI: 10.1186/s12951-023-02257-8.